Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ9L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,355
Award facts
- Contract value 100% obligated
- $40,355.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $40,355.27 by the Defense Logistics Agency on January 22, 2026, for the supply of Otezla 30 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 23, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive pharmaceutical supply vehicle for military healthcare programs globally.
Otezla is an immunosuppressive medication primarily used in the treatment of psoriasis, psoriatic arthritis, and other inflammatory conditions. This delivery order exemplifies Amerisourcebergen's critical role in the federal medical supply chain, providing both brand-name and generic pharmaceuticals to support military treatment facilities and defense healthcare systems. The non-set-aside competitive award designation underscores the contractor's established capability to meet federal pharmaceutical procurement requirements and maintain continuity of essential medications for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJJ9L?
SPE2DR26FJJ9L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FJJ9L worth?
The government has obligated $40,355 on SPE2DR26FJJ9L.
Is contract SPE2DR26FJJ9L an order under another contract?
Yes. SPE2DR26FJJ9L is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ9L competed?
The extent of competition for SPE2DR26FJJ9L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award